[Treatment of the menopause syndrome with dehydroepiandrosterone sulfate].
D000284:Administration, Oral; D000736:Androstenes / Q000097:blood; D000738:Androsterone / Q000097:blood; D003687:Dehydroepiandrosterone / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004717:Endometrium / Q000187:drug effects; D004967:Estrogens / Q000032:analysis / Q000627:therapeutic use / Q000652:urine; D005043:Etiocholanolone / Q000097:blood; D005260:Female; D006062:Gonadotropins / Q000032:analysis / Q000652:urine; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007408:Intestinal Absorption; D008593:Menopause / Q000187:drug effects*; D013431:Sulfates / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use; D013739:Testosterone / Q000097:blood; D014316:Tritium; D014626:Vaginal Smears
D000736:Androstenes; D004967:Estrogens; D006062:Gonadotropins; D013431:Sulfates; D014316:Tritium; D013739:Testosterone; D003687:Dehydroepiandrosterone; D005043:Etiocholanolone; D000738:Androsterone; D006854:Hydrocortisone
Behandlung des Menopausensyndroms mit Dehydroepiandrosteron-Sulfat.